Sumary of Zimbabwe: Boost for Local Pharmaceutical Sector:
- Zimbabwe is looking at boosting local production of pharmaceutical products to reduce over-reliance on imports, which at times presents a huge potential risk to national health security, according to a new Government policy document launched in Harare yesterday..
- The impact of the coronavirus pandemic on global medical consumables supply chains also require localisation of production of pharmaceutical products to ensure total control and citizens’ security..
- launched by Vice President Chiwenga, also aims to address some of the challenges besetting the industry including doubling production of essential drugs to 60 percent and grow revenue to US$150 million from about US$32 million..
- “The low levels of production have been attributed to industry producing pharmaceuticals products which are not on high demand and limited procurement by Government institutions amongst other things,”.
- There are only two local companies nearing compliance while the other six facilities have been considered unsuitable for pharmaceutical production, according to the document..
- The opening up of new markets through implementation of regional trade agreements at SADC, COMESA and the recently launched African Continental Free Trade Area (AfCFTA) presents an opportunity for ready export markets for local firms…